Lonza to sell two plants to NextPharma as it plows ahead with $93M capsule expansion
Swiss CDMO Lonza put down a major down payment in October to boost capsule manufacturing by 15% across eight global sites. Now, it’s looking to...
Pharma
AstraZeneca, Daiichi Sankyo push Enhertu closer to the blockbuster frontier with stomach cancer OK
Daiichi Sankyo and partner AstraZeneca have taken their HER2-targeted cancer drug Enhertu another step toward blockbusterland. The FDA cleared Enhertu for HER2-positive gastric or gastroesophageal...
Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild...
Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site
That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, Massachusetts—the second it’s announced in a little over a week....
Bayer transforms pharma business through breakthrough innovation in healthcare
At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients...
He’s in! Shark Tank’s Mark Cuban launches generics maker promising ‘radically’ low-cost drugs
Billionaire investor Mark Cuban is famous for critiquing startup plans on the hit TV series “Shark Tank,” often dismissing would-be entrepreneurs with the show’s famous...
What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here’s what BeiGene CEO has to say
BeiGene has had a few busy weeks. In its home base of China, the company won national reimbursement for three products. Outside of China, it...
CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout
Catalent hustled to expand its manufacturing capacity last year as it juggled a surge of COVID-19 work with its regular production orders. That pandemic agenda caused problems in...
JPM: Sanofi’s new chief digital officer steps up ambitions in marketing, research and even e-commerce
Sanofi CEO Paul Hudson came on the job touting his digital hopes for the company, and now he’s aiming to take the French drugmaker to...
Meet EUROAPI: Sanofi christens to-be-spun-off drug ingredients business, taps CEO
Sanofi has tied a name—and a new chief executive—to the European drug ingredients business it plans to spin off next year. Now dubbed EUROAPI, the active...